| Symbol | AUSAF |
|---|---|
| Name | AUSTRALIS CAPITAL INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 89139 United States NV 5898 Azzura Palms Avenue Suite 190 |
| Telephone | +1 800-898-0648 |
| Fax | — |
| — | |
| Website | http://www.ausa-corp.com |
| Incorporation | CA |
| Incorporated On | 2015 |
| Employees | — |
| Fiscal Year | 3/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Macias Gini & OConnell LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Foreign Issuer - Not Listed on Foreign Exchange |
| CIK | 0001758409 |
| Description | AUSA is implementing a capital light growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSAs business and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington. AUSA is currently working towards the closing of a transaction whereby it will acquire 100% of the membership interests in Green Therapeutics LLC, an award-winning MSO with operations in Nevada, Missouri and Oklahoma. Furthermore, the Company is working towards completing the acquisition of ALPS, the worlds premier design, construction management, commissioning and post commissioning consultancy company for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. Through GT and ALPS, the Company believes it will be able to secure low-cost access to cannabis biomass to fuel the scale up of its award-winning brands across the U.S. and global cannabis markets. Additional info from OTC: |
No news found.